Literature DB >> 3008786

Structure of the O-chain polysaccharide of the phenol-phase soluble lipopolysaccharide of Escherichia coli 0:157:H7.

M B Perry, L MacLean, D W Griffith.   

Abstract

The phenol-phase soluble lipopolysaccharide isolated from Escherichia coli 0:157 by the hot phenol-water extraction procedure was shown by sodium dodecyl sulfate-polyacrylamide gel electrophoresis, periodate oxidation, methylation, and 13C and 1H nuclear magnetic resonance studies to be an unbranched linear polysaccharide with a tetrasaccharide repeating unit having the structure: (formula; see text) The serological cross-reactivity of E. coli 0:157 with Brucella abortus, Yersinia enterocolitica (serotype 0:9), group N Salmonella, and some other E. coli species can be related immunochemically to the presence of 1,2-glycosylated N-acylated 4-amino-4, 6-dideoxy-alpha-D-mannopyranosyl residues in the O-chains of their respective lipopolysaccharides.

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3008786     DOI： 10.1139/o86-004

Source DB:  PubMed          Journal:  Biochem Cell Biol        ISSN： 0829-8211            Impact factor:   3.626


  40 in total

1.  Acquisition of the rfb-gnd cluster in evolution of Escherichia coli O55 and O157.

Authors:  P I Tarr; L M Schoening; Y L Yea; T R Ward; S Jelacic; T S Whittam
Journal:  J Bacteriol       Date:  2000-11       Impact factor: 3.490

2.  Structural and genetic characterization of glycosylation of type a flagellin in Pseudomonas aeruginosa.

Authors:  M Schirm; S K Arora; A Verma; E Vinogradov; P Thibault; R Ramphal; S M Logan
Journal:  J Bacteriol       Date:  2004-05       Impact factor: 3.490

3.  Functional analysis of ycfR and ycfQ in Escherichia coli O157:H7 linked to outbreaks of illness associated with fresh produce.

Authors:  Kaiping Deng; Siyun Wang; Xiaoqian Rui; Wei Zhang; Mary Lou Tortorello
Journal:  Appl Environ Microbiol       Date:  2011-04-15       Impact factor: 4.792

4.  Production and characterization of monoclonal antibodies specific for the lipopolysaccharide of Escherichia coli O157.

Authors:  R B Westerman; Y He; J E Keen; E T Littledike; J Kwang
Journal:  J Clin Microbiol       Date:  1997-03       Impact factor: 5.948

5.  Characterization of smooth lipopolysaccharides and O polysaccharides of Brucella species by competition binding assays with monoclonal antibodies.

Authors:  V Weynants; D Gilson; A Cloeckaert; A Tibor; P A Denoel; F Godfroid; J N Limet; J J Letesson
Journal:  Infect Immun       Date:  1997-05       Impact factor: 3.441

6.  Rapid hydrophobic grid membrane filter-enzyme-labeled antibody procedure for identification and enumeration of Escherichia coli O157 in foods.

Authors:  E C Todd; R A Szabo; P Peterkin; A N Sharpe; L Parrington; D Bundle; M A Gidney; M B Perry
Journal:  Appl Environ Microbiol       Date:  1988-10       Impact factor: 4.792

7.  Catalytic mechanism of perosamine N-acetyltransferase revealed by high-resolution X-ray crystallographic studies and kinetic analyses.

Authors:  James B Thoden; Laurie A Reinhardt; Paul D Cook; Patrick Menden; W W Cleland; Hazel M Holden
Journal:  Biochemistry       Date:  2012-04-10       Impact factor: 3.162

8.  Substrate specificity of bacterial oligosaccharyltransferase suggests a common transfer mechanism for the bacterial and eukaryotic systems.

Authors:  Michael Wacker; Mario F Feldman; Nico Callewaert; Michael Kowarik; Bradley R Clarke; Nicola L Pohl; Marcela Hernandez; Enrique D Vines; Miguel A Valvano; Chris Whitfield; Markus Aebi
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-25       Impact factor: 11.205

9.  The serological relationship between Escherichia coli O157 and Yersinia enterocolitica O9 using sera from patients with brucellosis.

Authors:  H Chart; O A Okubadejo; B Rowe
Journal:  Epidemiol Infect       Date:  1992-02       Impact factor: 2.451

10.  The serological relationship between Yersinia enterocolitica O9 and Escherichia coli O157 using sera from patients with yersiniosis and haemolytic uraemic syndrome.

Authors:  H Chart; T Cheasty; D Cope; R J Gross; B Rowe
Journal:  Epidemiol Infect       Date:  1991-10       Impact factor: 2.451
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.